NPORT-EX 2 acmo_smallcapgrowth.htm PART F Document

American Century Investments®
Quarterly Portfolio Holdings
Small Cap Growth Fund
January 31, 2023



Small Cap Growth Fund - Schedule of Investments
JANUARY 31, 2023 (UNAUDITED)
Shares/
Principal Amount ($)
Value ($)
COMMON STOCKS — 97.2%
Aerospace and Defense — 2.7%
Aerojet Rocketdyne Holdings, Inc.(1)
264,992 14,818,353 
CAE, Inc.(1)
891,197 20,127,368 
Mercury Systems, Inc.(1)
520,628 26,023,591 
60,969,312 
Auto Components — 2.2%
Fox Factory Holding Corp.(1)
288,929 34,119,625 
Gentherm, Inc.(1)
198,755 14,793,335 
48,912,960 
Banks — 1.4%
Bancorp, Inc.(1)
527,461 17,896,752 
Commerce Bancshares, Inc.
208,153 13,854,663 
31,751,415 
Beverages — 1.7%
Duckhorn Portfolio, Inc.(1)
1,179,481 19,084,003 
MGP Ingredients, Inc.
201,893 19,692,643 
38,776,646 
Biotechnology — 8.2%
ADMA Biologics, Inc.(1)
1,020,915 3,767,176 
Apellis Pharmaceuticals, Inc.(1)
207,517 10,942,371 
Arcus Biosciences, Inc.(1)
92,525 2,001,316 
Arcutis Biotherapeutics, Inc.(1)
464,824 7,702,134 
Biohaven Ltd.(1)
380,310 7,260,118 
Blueprint Medicines Corp.(1)
185,104 8,651,761 
Celldex Therapeutics, Inc.(1)
146,095 6,436,946 
Centessa Pharmaceuticals PLC, ADR(1)(2)
464,785 1,859,140 
Cerevel Therapeutics Holdings, Inc.(1)
230,393 7,867,921 
Cytokinetics, Inc.(1)
384,092 16,316,228 
Halozyme Therapeutics, Inc.(1)
395,280 20,463,645 
Insmed, Inc.(1)
527,254 11,351,779 
Intellia Therapeutics, Inc.(1)
103,689 4,400,561 
IVERIC bio, Inc.(1)
277,516 6,410,620 
Karuna Therapeutics, Inc.(1)
72,305 14,416,894 
Keros Therapeutics, Inc.(1)
103,110 6,039,153 
Kymera Therapeutics, Inc.(1)
94,131 3,518,617 
Madrigal Pharmaceuticals, Inc.(1)
27,294 7,867,495 
Natera, Inc.(1)
488,298 20,962,633 
Prometheus Biosciences, Inc.(1)
90,544 10,291,231 
Relay Therapeutics, Inc.(1)
197,367 4,235,496 
182,763,235 
Building Products — 2.5%
AZEK Co., Inc.(1)
710,608 17,146,971 
Hayward Holdings, Inc.(1)
1,515,183 20,439,819 
Trex Co., Inc.(1)
339,716 17,909,827 
55,496,617 
Capital Markets — 1.2%
LendingTree, Inc.(1)
183,688 7,285,066 
StepStone Group, Inc., Class A
669,103 19,531,117 
26,816,183 



Chemicals — 1.0%
Diversey Holdings Ltd.(1)
1,515,924 9,201,659 
Perimeter Solutions SA(1)
1,484,821 13,808,835 
23,010,494 
Commercial Services and Supplies — 3.6%
Clean Harbors, Inc.(1)
245,121 31,939,266 
Driven Brands Holdings, Inc.(1)
1,157,041 33,774,027 
Korn Ferry
269,399 14,544,852 
80,258,145 
Communications Equipment — 1.5%
Ciena Corp.(1)
295,190 15,355,784 
Credo Technology Group Holding Ltd.(1)
518,096 8,978,604 
Extreme Networks, Inc.(1)
507,349 9,147,502 
33,481,890 
Construction and Engineering — 0.8%
Construction Partners, Inc., Class A(1)
637,635 18,038,694 
Construction Materials — 1.5%
Eagle Materials, Inc.
79,405 11,599,483 
Summit Materials, Inc., Class A(1)
645,112 21,198,380 
32,797,863 
Containers and Packaging — 1.3%
AptarGroup, Inc.
98,205 11,356,426 
Graphic Packaging Holding Co.
761,289 18,339,452 
29,695,878 
Diversified Consumer Services — 0.8%
European Wax Center, Inc., Class A
952,118 17,937,903 
Electric Utilities — 0.6%
IDACORP, Inc.
124,888 13,214,399 
Electrical Equipment — 0.9%
Sensata Technologies Holding PLC
400,638 20,372,442 
Electronic Equipment, Instruments and Components — 1.8%
Jabil, Inc.
198,930 15,641,866 
National Instruments Corp.
429,721 23,204,934 
38,846,800 
Energy Equipment and Services — 1.7%
Expro Group Holdings NV(1)
828,299 15,646,568 
Weatherford International PLC(1)
397,383 22,603,145 
38,249,713 
Equity Real Estate Investment Trusts (REITs) — 0.8%
Ryman Hospitality Properties, Inc.
185,755 17,254,782 
Food and Staples Retailing — 1.4%
BJ's Wholesale Club Holdings, Inc.(1)
208,029 15,075,862 
Grocery Outlet Holding Corp.(1)
545,999 16,592,909 
31,668,771 
Food Products — 2.3%
Freshpet, Inc.(1)
328,089 20,777,876 
Sovos Brands, Inc.(1)
1,104,101 14,971,610 
SunOpta, Inc.(1)
1,994,786 16,297,402 
52,046,888 
Health Care Equipment and Supplies — 5.2%
Establishment Labs Holdings, Inc.(1)(2)
232,991 15,852,708 
Inari Medical, Inc.(1)
338,826 19,330,023 
Lantheus Holdings, Inc.(1)
282,659 16,252,893 
SI-BONE, Inc.(1)
997,511 16,987,612 
Silk Road Medical, Inc.(1)
447,237 24,311,803 



TransMedics Group, Inc.(1)
350,195 22,069,289 
114,804,328 
Health Care Providers and Services — 5.9%
Acadia Healthcare Co., Inc.(1)
231,902 19,484,406 
AdaptHealth Corp.(1)
499,647 10,707,435 
Ensign Group, Inc.
246,378 22,974,749 
HealthEquity, Inc.(1)
403,657 24,562,528 
Progyny, Inc.(1)
389,480 13,394,217 
R1 RCM, Inc.(1)
1,835,676 26,268,524 
Surgery Partners, Inc.(1)
386,969 12,847,371 
130,239,230 
Health Care Technology — 1.4%
Evolent Health, Inc., Class A(1)
635,613 20,479,451 
Schrodinger, Inc.(1)
405,562 9,806,489 
30,285,940 
Hotels, Restaurants and Leisure — 4.2%
Churchill Downs, Inc.
119,894 29,745,701 
Planet Fitness, Inc., Class A(1)
469,293 39,725,653 
Wingstop, Inc.
152,174 24,115,014 
93,586,368 
Insurance — 2.8%
Kinsale Capital Group, Inc.
105,409 29,350,082 
RLI Corp.
189,701 25,125,898 
Skyward Specialty Insurance Group Inc.(1)
460,614 8,525,965 
63,001,945 
Interactive Media and Services — 1.3%
Eventbrite, Inc., Class A(1)
1,395,321 12,404,404 
QuinStreet, Inc.(1)
1,103,238 16,912,638 
29,317,042 
IT Services — 0.4%
Perficient, Inc.(1)
132,828 9,847,868 
Leisure Products — 1.9%
Brunswick Corp.
232,662 19,620,386 
Topgolf Callaway Brands Corp.(1)
916,073 22,434,628 
42,055,014 
Life Sciences Tools and Services — 0.4%
MaxCyte, Inc.(1)
1,513,490 8,838,782 
Machinery — 2.4%
Astec Industries, Inc.
374,386 16,525,398 
ATS Corp.(1)
737,931 29,882,171 
Greenbrier Cos., Inc.
206,223 6,376,415 
52,783,984 
Multiline Retail — 0.5%
Ollie's Bargain Outlet Holdings, Inc.(1)
210,037 11,501,626 
Oil, Gas and Consumable Fuels — 4.8%
Kosmos Energy Ltd.(1)
5,546,069 43,869,406 
Matador Resources Co.
283,464 18,753,978 
Transocean Ltd.(1)
1,507,883 10,163,132 
Whitecap Resources, Inc.(2)
4,135,727 34,470,867 
107,257,383 
Pharmaceuticals — 2.5%
Arvinas, Inc.(1)
167,296 5,482,290 
Edgewise Therapeutics, Inc.(1)(2)
453,680 4,641,146 
Harmony Biosciences Holdings, Inc.(1)
129,326 6,229,633 
Intra-Cellular Therapies, Inc.(1)
309,793 14,845,281 



Option Care Health, Inc.(1)
498,869 14,402,348 
Ventyx Biosciences, Inc.(1)
227,291 9,546,222 
55,146,920 
Professional Services — 0.3%
CACI International, Inc., Class A(1)
22,310 6,873,488 
Real Estate Management and Development — 1.8%
Altus Group Ltd.(2)
262,479 11,232,614 
DigitalBridge Group, Inc.
784,496 11,610,541 
FirstService Corp.(2)
118,214 16,894,060 
39,737,215 
Road and Rail — 0.9%
Saia, Inc.(1)
73,001 19,913,213 
Semiconductors and Semiconductor Equipment — 4.5%
Ambarella, Inc.(1)
82,591 7,419,975 
Lattice Semiconductor Corp.(1)
470,694 35,673,898 
MACOM Technology Solutions Holdings, Inc.(1)
218,140 14,619,743 
Onto Innovation, Inc.(1)
203,860 16,033,589 
Power Integrations, Inc.
303,419 26,121,342 
99,868,547 
Software — 9.5%
Box, Inc., Class A(1)
799,701 25,582,435 
Five9, Inc.(1)
264,082 20,804,380 
JFrog Ltd.(1)
878,182 22,578,059 
Manhattan Associates, Inc.(1)
188,596 24,585,374 
nCino, Inc.(1)
547,100 15,647,060 
Paycor HCM, Inc.(1)
562,246 14,117,997 
Paylocity Holding Corp.(1)
93,344 19,442,622 
Sprout Social, Inc., Class A(1)
185,025 11,836,049 
SPS Commerce, Inc.(1)
159,134 21,654,955 
Tenable Holdings, Inc.(1)
851,273 34,246,713 
210,495,644 
Specialty Retail — 0.5%
Leslie's, Inc.(1)
642,307 9,949,335 
Technology Hardware, Storage and Peripherals — 0.6%
Pure Storage, Inc., Class A(1)
475,072 13,748,584 
Textiles, Apparel and Luxury Goods — 1.6%
Crocs, Inc.(1)
292,018 35,559,032 
Trading Companies and Distributors — 2.8%
H&E Equipment Services, Inc.
484,301 24,646,078 
MRC Global, Inc.(1)
1,036,273 14,093,313 
NOW, Inc.(1)
1,600,739 22,474,375 
61,213,766 
Water Utilities — 1.1%
SJW Group
314,192 24,321,603 
TOTAL COMMON STOCKS
(Cost $1,946,726,650)
2,162,707,887 
SHORT-TERM INVESTMENTS — 4.8%
Money Market Funds — 1.7%
State Street Institutional U.S. Government Money Market Fund, Premier Class
87,847 87,847 
State Street Navigator Securities Lending Government Money Market Portfolio(3)
37,070,784 37,070,784 
37,158,631 
Repurchase Agreements — 3.1%
BMO Capital Markets Corp., (collateralized by various U.S. Treasury obligations, 2.875%, 10/31/23 - 11/30/23, valued at $17,106,411), in a joint trading account at 4.22%, dated 1/31/23, due 2/1/23 (Delivery value $16,769,887)
16,767,921 



Fixed Income Clearing Corp., (collateralized by various U.S. Treasury obligations, 3.875%, 1/15/2026, valued at $53,991,750), at 4.28%, dated 1/31/23, due 2/1/23 (Delivery value $52,939,293)
52,933,000 
69,700,921 
TOTAL SHORT-TERM INVESTMENTS
(Cost $106,859,552)
106,859,552 
TOTAL INVESTMENT SECURITIES—102.0%
(Cost $2,053,586,202)
2,269,567,439 
OTHER ASSETS AND LIABILITIES (2.0)%
(43,839,090)
TOTAL NET ASSETS — 100.0%
$2,225,728,349 

FORWARD FOREIGN CURRENCY EXCHANGE CONTRACTS
Currency PurchasedCurrency SoldCounterpartySettlement
Date
Unrealized
Appreciation
(Depreciation)
CAD2,582,027 USD1,901,371 Goldman Sachs & Co.3/31/23$40,031 
USD78,467,247 CAD107,280,420 Goldman Sachs & Co.3/31/23(2,195,886)
USD3,239,389 CAD4,407,545 Goldman Sachs & Co.3/31/23(74,603)
USD2,470,713 CAD3,359,349 Goldman Sachs & Co.3/31/23(55,150)
USD2,618,447 CAD3,570,844 Goldman Sachs & Co.3/31/23(66,437)
USD2,420,164 CAD3,306,660 Goldman Sachs & Co.3/31/23(66,083)
USD2,772,039 CAD3,720,133 Goldman Sachs & Co.3/31/23(25,093)
USD2,208,696 CAD2,950,588 Goldman Sachs & Co.3/31/23(9,823)
USD2,336,813 CAD3,132,924 Goldman Sachs & Co.3/31/23(18,802)
USD2,650,266 CAD3,539,385 Goldman Sachs & Co.3/31/23(10,964)
$(2,482,810)

NOTES TO SCHEDULE OF INVESTMENTS
ADRAmerican Depositary Receipt
CADCanadian Dollar
USDUnited States Dollar
(1)Non-income producing.
(2)Security, or a portion thereof, is on loan. At the period end, the aggregate value of securities on loan was $44,750,971. The amount of securities on loan indicated may not correspond with the securities on loan identified because securities with pending sales are in the process of recall from the brokers.
(3)Investment of cash collateral from securities on loan. At the period end, the aggregate value of the collateral held by the fund was $47,012,304, which includes securities collateral of $9,941,520.



SUPPLEMENTARY NOTES TO SCHEDULE OF INVESTMENTS

1. Investment Valuations

The fund determines the fair value of its investments and computes its net asset value (NAV) per share at the close of regular trading (usually 4 p.m. Eastern time) on the New York Stock Exchange (NYSE) on each day the NYSE is open. The value of investments of the fund is determined by American Century Investment Management, Inc. (ACIM) (the investment advisor), as the valuation designee, pursuant to its valuation policies and procedures. The Board of Directors oversees the valuation designee and reviews its valuation policies and procedures at least annually. 

Equity securities that are listed or traded on a domestic securities exchange are valued at the last reported sales price or at the official closing price as provided by the exchange. Equity securities traded on foreign securities exchanges are generally valued at the closing price of such securities on the exchange where primarily traded or at the close of the NYSE, if that is earlier. If no last sales price is reported, or if local convention or regulation so provides, the mean of the latest bid and asked prices may be used. Securities traded over-the-counter are valued at the mean of the latest bid and asked prices, the last sales price, or the official closing price. Equity securities initially expressed in local currencies are translated into U.S. dollars at the mean of the appropriate currency exchange rate at the close of the NYSE as provided by an independent pricing service.

Open-end management investment companies are valued at the reported NAV per share. Repurchase agreements are valued at cost, which approximates fair value. Forward foreign currency exchange contracts are valued at the mean of the appropriate forward exchange rate at the close of the NYSE as provided by an independent pricing service.

If the valuation designee determines that the market price for a portfolio security is not readily available or is believed by the valuation designee to be unreliable, such security is valued at fair value as determined in good faith by the valuation designee, in accordance with its policies and procedures. Circumstances that may cause the fund to determine that market quotations are not available or reliable include, but are not limited to: when there is a significant event subsequent to the market quotation; trading in a security has been halted during the trading day; or trading in a security is insufficient or did not take place due to a closure or holiday.

The valuation designee monitors for significant events occurring after the close of an investment’s primary exchange but before the fund’s NAV per share is determined. Significant events may include, but are not limited to: corporate announcements and transactions; regulatory news, governmental action and political unrest that could impact a specific investment or an investment sector; or armed conflicts, natural disasters and similar events that could affect investments in a specific country or region. The valuation designee also monitors for significant fluctuations between domestic and foreign markets, as evidenced by the U.S. market or such other indicators that it deems appropriate. The valuation designee may apply a model-derived factor to the closing price of equity securities traded on foreign securities exchanges. The factor is based on observable market data as provided by an independent pricing service.

2. Fair Value Measurements

The fund's investments valuation process is based on several considerations and may use multiple inputs to determine the fair value of the investments held by the fund. In conformity with accounting principles generally accepted in the United States of America, the inputs used to determine a valuation are classified into three broad levels. 

Level 1 valuation inputs consist of unadjusted quoted prices in an active market for identical investments.

Level 2 valuation inputs consist of direct or indirect observable market data (including quoted prices for comparable investments, evaluations of subsequent market events, interest rates, prepayment speeds, credit risk, etc.). These inputs also consist of quoted prices for identical investments initially expressed in local currencies that are adjusted through translation into U.S. dollars. 

Level 3 valuation inputs consist of unobservable data (including a fund’s own assumptions).

The level classification is based on the lowest level input that is significant to the fair valuation measurement. The valuation inputs are not necessarily an indication of the risks associated with investing in these securities or other financial instruments.




The following is a summary of the level classifications as of period end. The Schedule of Investments provides additional information on the fund's portfolio holdings.
Level 1Level 2Level 3
Assets
Investment Securities
Common Stocks
Aerospace and Defense$40,841,944 $20,127,368 — 
Machinery22,901,813 29,882,171 — 
Oil, Gas and Consumable Fuels72,786,516 34,470,867 — 
Real Estate Management and Development11,610,541 28,126,674 — 
Other Industries1,901,959,993 — — 
Short-Term Investments37,158,631 69,700,921 — 
$2,087,259,438 $182,308,001 — 
Other Financial Instruments
Forward Foreign Currency Exchange Contracts— $40,031 — 
Liabilities
Other Financial Instruments
Forward Foreign Currency Exchange Contracts— $2,522,841 — 
This schedule of investments provides information about the fund’s portfolio holdings as of the date on the schedule. It is unaudited, and American Century Investments assumes no obligation to update or supplement the schedule to reflect subsequent changes. More information is available in the fund’s most recent annual or semiannual shareholder report.